A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations

por Van Hoeven, Neal, Joshi, Sharvari Waghmare, Nana, Ghislain Ismael, Bosco-Lauth, Angela, Fox, Christopher, Bowen, Richard A., Clements, David E., Martyak, Timothy, Parks, D. Elliot, Baldwin, Susan, Reed, Steven G., Coler, Rhea N.
Publicado 2016